California-based Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration ...

Netherlands-based venture capital firm Forbion has raised over €2 billion ($2.2 billion) across its newest funds, bringing ...

The American Lung Association Research Institute has announced a $22 million investment in 2024 to fund 139 research grants ...

Eli Lilly has announced a strategic collaboration with UK government departments to address population health challenges, ...

TenNor Therapeutics has raised over 300 million yuan ($41 million) in a series E round, led by AMR Action Fund, to advance ...

Chinese biopharma Hutchmed (LON: HCM) was trading 5% higher at the mid-point of London’s trading day on Wednesday. The ...

A staggering 800% increase in licensing agreement deal values for messenger ribonucleic acid (mRNA)-based innovator ...

TRIANA Biomedicines has entered into a strategic collaboration and licensing agreement with US pharma giant Pfizer to ...

Nuclera has raised $75 million, led by Elevage Medical Technologies, to commercialize its eProtein Discovery system. The ...

Eli Lilly (NYSE: LLY) has partnered with the UK government, investing £279 million ($340 million) to address public health ...

Johnson & Johnson has announced positive Phase II/III trial results for nipocalimab in generalized myasthenia gravis (gMG). The drug showed significant IgG reduction and sustained disease control.

The US Food and Drug Administration (FDA) has approved Novocure's Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or ...